Dr. Joshua Sestak currently serves as the Chief Operating Officer of UI Pharmaceuticals. Joshua has extensive experience in early-stage drug development within the pharmaceutical industry including bringing first in class therapies into the clinic. Joshua’s R&D experience has focused on the development of immune therapeutics, siRNA formulations, as well as novel delivery of peptide therapeutics. He also brings expertise in completion of CMC requirements to support IND filing and clinical entry. Most recently he served as the CEO of Orion BioScience, a biotech start-up developing novel autoimmune therapeutics focused on re-establishing tolerance in early-stage patients with autoimmune diseases such as Type-1 Diabetes and Neuromyelitis Optica. Outside of work he enjoys exploring and spending time outdoors with his wife and four children. Joshua earned his Ph.D. in Pharmaceutical Chemistry from the University of Kansas and holds a B.S. in Chemistry and Biochemistry from Gonzaga University.
